Federal Register notice: FDA seeks comments on an information collection extension entitled State Enforcement Notifications 21 CFR 100.2(d).
Federal Register notice: FDA announces the issuance of a priority review voucher to Rhythm Pharmaceuticals related to its rare pediatric disease produ...
FDA publishes a guidance on how generic drug manufacturers can submit controlled correspondence to FDA seeking generic drug development information.
Federal Register notice: FDA issues of a priority review voucher to Eiger BioPharmaceuticals that is related to its rare pediatric disease product NDA...
FDA advisors back an expanded indication for Novartis heart failure drug Entresto but cant specify a patient group.
FDA grants a de novo marketing authorization for Miach Orthopedics anterior cruciate ligament (ACL) implant for ACL reconstruction in patients with AC...
FDA issues Abbott an Emergency Use Authorization for its virtually guided at-home use BinaxNOW Covid-19 Ag Card rapid test for detecting Covid-19 infe...
YourEncore consultants describe in a white paper the value of having a clinical trial data strategy.